Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Resonance Health.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Alcidion wins Aussie government contract, while Resonance seeks US FDA nod
Health & Biotech
ASX Health: 4D Medical jumps 16pc on lungs device rollout, Proteomics up 10pc on UK deal
Health & Biotech
ASX Health Stocks: Cannabis play AusCann commences study of CBD on spinal cord injury
News
Market Highlights and 5 ASX Small Caps to watch on Friday
Health & Biotech
ASX Health Wrap: Resonance gains ground, with sights set on FDA approval for LiverSmart
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
News
ASX Health Stocks: Medical imaging player Resonance Health leads the pack with FY21 revenue increase
News
Market highlights and 5 ASX small caps to watch on Friday
News
Market highlights and 5 ASX small caps to watch on Monday
News
Market highlights and 5 ASX small caps to watch on Monday
Health & Biotech
Regulatory approvals gave both these ASX healthcare small caps a rocket today
Health & Biotech
Medical devices tracker: All the life-saving gadgets ASX companies are working on right now
Experts
ScoPo’s health powerplays: ‘Cannabis stocks went on a ride’
News
ASX Small Cap Lunch Wrap: Who’s getting jabbed today?
Health & Biotech
Resonance Health shares surge after its liver health monitoring software gets FDA approval
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech